Merck seeks OTC status for Mevacor

10/23/2007 | CNNMoney

The FDA will ask a panel of outside experts to review data supporting the use of Merck's cholesterol-lowering drug Mevacor as an over-the-counter treatment. If approved as a nonprescription medication, Merck aims to market Mevacor as a once-a-day drug to prevent heart attacks and control cholesterol levels.

View Full Article in:

CNNMoney

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Clinical Trials Agreements Specialist (209955)
The Henry M. Jackson Foundation for the Advancement of Military Medicine Inc.
Rockville, MD
SAFETY, HEALTH, and ENVIRONMENTAL (SHE) REGIONAL SPECIALIST
Matheson Tri-Gas, Inc.
Newark, CA
Catheter Engineer
ASAHI INTECC, Orange County CA R&D Center
Santa Ana, CA
MANAGER MEDICAL GAS COMPLIANCE AND SAFETY
Matheson Tri-Gas, Inc.
Houston, TX
Neurovascular Intervention Product Sales Rep, North East
ASAHI INTECC
Multiple Locations, SL_Multiple Locations